11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study-Reference-Cited by-同舟云学术

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Published:2010-04 Issue:4 Volume:9 Page:363-372
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Rinne Juha O,Brooks David J,Rossor Martin N,Fox Nick C,Bullock Roger,Klunk William E,Mathis Chester A,Blennow Kaj,Barakos Jerome,Okello Aren A,de LIano Sofia Rodriguez Martinez,Liu Enchi,Koller Martin,Gregg Keith M,Schenk Dale,Black Ronald,Grundman Michael

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference35 articles.

1. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics;Selkoe;Annu Rev Pharmacol Toxicol,2003

2. Immunotherapy reduces vascular amyloid-beta in PDAPP mice;Schroeter;J Neurosci,2008

3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease;Bard;Nat Med,2000

4. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory;Shankar;Nat Med,2008

5. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer's disease;Salloway;Neurology,2009

Cited by 643 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer’s disease;Med;2024-09

2. C–H Labeling with [¹⁸F]Fluoride: An Emerging Methodology in Radiochemistry;ACS Central Science;2024-08-23

3. Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders;International Journal of Molecular Sciences;2024-06-18

4. Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells;Immunity & Ageing;2024-06-14

5. Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities;Scientific Reports;2024-05-13